Skip links

Navigating Generative AI: Separating Hype from Real-world Outcomes

Jump To Section

Leveraging generative AI, Generative AI Stratergy, Agile Business Transformation, Data quality management

In today’s business landscape, the hype around GenAI continues to reach new heights, driving companies to pour billions into AI-driven initiatives. Yet many organizations find themselves grappling with data issues, complex technology environments, and silos making it difficult to leverage AI in a holistic way. This often leads to making hefty investments in digital transformation that yield minimal returns.

CEOs and board members, captivated by the allure of GenAI’s seemingly unlimited capabilities, often envision it as a turnkey solution that operates on autopilot. Our experience working with numerous clients reveals that achieving effectiveness with GenAI requires that the business take the ownership with a holistic approach coupled with operations rigor, data quality, and collaboration across all stakeholders.

Overcoming Data Challenges to Unlock GenAI’s Potential

Numerous challenges obstruct the path to AI success such as complex processes, disparate tech tools, a lack of an enterprise-wide approach to data management characterized by scattered repositories and data sources, an absence of Master Data Management (MDM) practices, and silos. The lack of holistic data management undermines businesses’ ability to harness insights from their data, impeding informed decision-making and limiting innovation. According to a Databricks CIO Survey, 72% of business leaders said that data problems were more likely than other factors to jeopardize their achievement of AI goals.

Despite these challenges there is opportunity to create value through GenAI and propel companies to a new level of success. However, unlocking this value necessitates a back-to-basics approach, steering businesses away from complex silos and legacy environments towards a business-facing model anchored in the latest cloud technologies. This involves implementing a structured, step-by-step strategy supported by a Digital Business Methodology (DBM) and facilitated by a fully automated, cloud based Digital Business Platform (DBP) tailored to the client’s needs.

In practice, getting value from GenAI means avoiding a big bang approach and working within but away from existing complex environments and silos. Central to this approach is the importance of understanding each client’s business specific needs and technology environment—a cornerstone of our DBM.By consolidating disparate data sources and business operations into an enterprise wide cloud-based ecosystem, we empower businesses with the agility and culture to discern insights from data, fostering innovation and growth while avoiding the burden of technical debt.

Implementing a Holistic, Incremental Approach for AI Success

Start with the best suited use cases and streamlined operational processes. This approach enhances data quality, facilitates integration of business intuition, and is achieved through fully automated processes, end-to-end intelligent interfaces and real-time interactions. This paradigm shift not only  reduces the complexities inherent in traditional workflow tools it eliminates inefficiency of Excel spreadsheets, email, paper, etc. 

Additionally, leverage GenAI with appropriate large language models (LLMs) and algorithms to support business intuition based on data quality and their maturity to facilitate and align outcomes. The infrastructure supporting cloud platforms must meet a high standard of engineering rigor to mitigate risks and contain costs—a task that demands both expertise and experience. Infrastructure companies are expensive and take a more risky, boil the ocean approach. Drawing upon our real-world experience and proven methodology we have the proficiency to deliver consistent, scalable outcomes, addressing our clients’ concerns regardless of maturity level.

We have proven track record of success across multiple industries—ranging from financial services to pharmaceuticals and manufacturing—underscores the efficacy of this holistic incremental approach that has delivered higher productivity and real-world outcomes. Moreover, empowering businesses to take ownership and actively engage in the process not only fosters high-quality outcomes and innovation but also ensures compliance, security, and the creation of assets—be it data, products, or AI. This brings greater consistency, scale and speed within an agile, collaborative digital culture.

In a recent customer meeting it was clear that they needed a comprehensive approach and overhaul of Salesforce operations to produce stronger sales and marketing operations. Key pain points centered on a gap between business needs and solutions, addressing technical debt, inadequate testing processes, complex territory management, external vendor performance and dependency, subpar development talent and resistance to change. The solution called for the business to take ownership and prioritize its focus on low hanging fruit for quick wins. This was done with operations rigor, data quality crucial to understand AI models and use cases, and prompt engineering with Copilot.

In today’s business world, GenAI presents an opportunity to transcend the hype, but leveraging its potential requires overcoming challenges like data issues and silos. By embracing a simplified, back-to basics approach and prioritizing operational efficiency and data quality, businesses can unlock GenAI’s value. Our proven track record across multiple industries underscores the efficacy of our holistic DBM incremental approach, which empowers businesses to take ownership of their AI journey to drive unlimited outcomes and innovation within an agile, collaborative digital culture.

Picture of Raj Vattikuti

Raj Vattikuti

Raj Vattikuti is an American-Indian entrepreneur, business executive and philanthropist. He is the Founder and Chairman of Altimetrik Corp. He is also the founder of Vattikuti Foundation. through which he is involved in many charitable causes.

Suggested Reading

Ready to Unlock Your Enterprise's Full Potential?

Michael Woodall

Chief Growth Officer of Financial Services

Michael Woodall, as the Chief Growth Officer of Financial Services at Altimetrik, spearheads the identification of new growth avenues and revenue streams within the financial services sector. With a robust background and extensive expertise, Michael brings invaluable insights to his role.

Previously, Michael served as the Chief of Operations and President of the Trust Company at Putnam Investments, where he orchestrated strategic developments and continuous operational enhancements. Leveraging strategic partnerships and data analytics, he revolutionized capabilities across investments, retail and institutional distribution, and client services. Under his leadership, Putnam received numerous accolades, including the DALBAR Mutual Fund Service Award for over 30 consecutive years.

Michael’s dedication to industry evolution is evident through his involvement with prestigious organizations such as the DTCC Senior Wealth Advisory Board, ICI Operations Committee, and NICSA, where he served as Chairman and now holds the position of Director Emeritus. Widely recognized as an industry luminary, Michael frequently shares his expertise with various divisions of the SEC, solidifying his reputation as a seasoned presenter.

At Altimetrik, Michael plays a pivotal role in driving expansion within financial services, leveraging his expertise and Altimetrik’s Digital Business Methodology to ensure clients navigate their digital journey seamlessly, achieving tangible outcomes and exponential growth.

Beyond his corporate roles, Michael serves as Chair of the Boston Water & Sewer Commission, appointed by the Mayor of Boston, and is actively involved in various philanthropic endeavors, including serving on the board of the nonprofit Inspire Arts & Music.

Michael holds a distinguished business degree from Northeastern University, graduating with distinction as a member of the Sigma Epsilon Rho Honor Society.

Anguraj Kumar Arumugam

Chief Digital Business Officer for the U.S. West region

Anguraj is an accomplished business executive with an extensive leadership experience in the services industry and strong background across digital transformation, engineering services, data and analytics, cloud and consulting.

Prior to joining Altimetrik, Anguraj has served in various positions and roles at Globant, GlobalLogic, Wipro and TechMahindra. Over his 25 years career, he has led many strategic and large-scale digital engineering and transformation programs for some of world’s best-known brands. His clients represent a range of industry sectors including Automotive, Technology and Software Platforms. Anguraj has built and guided all-star teams throughout his tenure, bringing together the best of the techno-functional capabilities to address critical client challenges and deliver value.

Anguraj holds a bachelor’s degree in mechanical engineering from Anna University and a master’s degree in software systems from Birla Institute of Technology, Pilani.

In his spare time, he enjoys long walks, hiking, gardening, and listening to music.

Vikas Krishan

Chief Digital Business Officer and Head of the EMEA region

Vikas (Vik) Krishan serves as the Chief Digital Business Officer and Head of the EMEA region for Altimetrik. He is responsible for leading and growing the company’s presence across new and existing client relationships within the region.

Vik is a seasoned executive and brings over 25 years of global experience in Financial Services, Digital, Management Consulting, Pre- and Post-deal services and large/ strategic transformational programmes, gained in a variety of senior global leadership roles at firms such as Globant, HCL, Wipro, Logica and EDS and started his career within Investment Banking. He has developed significant cross industry experience across a wide variety of verticals, with a particular focus on working with and advising the C-Suite of Financial Institutions, Private Equity firms and FinTech’s on strategy and growth, operational excellence, performance improvement and digital adoption.

He has served as the engagement lead on multiple global transactions to enable the orchestration of business, technology, and operational change to drive growth and client retention.

Vik, who is based in London, serves as a trustee for the Burma Star Memorial Fund, is a keen photographer and an avid sportsman.

Megan Farrell Herrmanns

Chief Digital Officer, US Central

Megan is a senior business executive with a passion for empowering customers to reach their highest potential. She has depth and breadth of experience working across large enterprise and commercial customers, and across technical and industry domains. With a track record of driving measurable results, she develops trusted relationships with client executives to drive organizational growth, unlock business value, and internalize the use of digital business as a differentiator.

At Altimetrik, Megan is responsible for expanding client relationships and developing new business opportunities in the US Central region. Her focus is on digital business and utilizing her experience to create high growth opportunities for clients. Moreover, she leads the company’s efforts in cultivating and enhancing our partnership with Salesforce, strategically positioning our business to capitalize on new business opportunities.

Prior to Altimetrik, Megan spent 10 years leading Customer Success at Salesforce, helping customers maximize the value of their investments across their technology stack. Prior to Salesforce, Megan spent over 15 years with Accenture, leading large transformational projects for enterprise customers.

Megan earned a Bachelor of Science in Mechanical Engineering from Marquette University. Beyond work, Megan enjoys playing sand volleyball, traveling, watching her kids soccer games, and is actively involved in a philanthropy (Advisory Council for Cradles to Crayons).

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes